Cosmo Pharma Lists Breezula Phase 3 Trial on ClinicalTrials.gov
    Research/Science 6/24/2023

    A phase 3 trial for Breezula (clascoterone solution) to treat male pattern hair loss has been listed, with 726 participants and a completion date of January 2025. Other treatments mentioned include Aneira Pharma's combination of minoxidil and latanoprost, Triple Hair's combination of minoxidil, latanoprost, and finasteride, and a new microneedling and LLLT device called StimuSIL.
    View this post in the Community →

    Similar Community Posts Join

    5 / 218 results

      community Switch from fin to dut and its worse

      in Finasteride/Dutasteride 1 day ago
      Switching from finasteride to dutasteride can worsen hair loss for some men due to increased testosterone levels. Topical treatments like RU58841 and Pyrilutamide are suggested to counteract these effects, but individual responses vary.

      community Breezula phase 3 results said to be released next month

      in Product  28 upvotes 5 months ago
      Breezula's phase 3 results are expected soon, with discussions on the effectiveness of androgen receptor antagonists like spironolactone and the potential of GT20029. Users express skepticism about new treatments and discuss the complexities of male pattern baldness, often relying on finasteride despite its side effects.

    Related Research

    6 / 11 results